~ an unrestricted cash award of $5,000 each;
~ recognition at CHADD’s Annual International Conference on ADHD
~ an allowance to cover most Conference-related expenses
~ a one-year CHADD professional membership.
Applicants must be in the process of completing a doctoral degree or have completed one within the last three years with the doctoral degree awarded no earlier than January 2010. They must be involved in conducting research addressing an area of ADHD that will further understanding of the disorder. The research may address any area relevant to ADHD, including, but not limited to:
~ biological/genetic underpinnings of the disorder
~ treatment efficacy
~ impact on the individual or family
~ school or workplace accommodations
~ social stigma and discrimination
~ public health
Applicants should submit a description of the research program (not more than 2 pages single-spaced) as well as any supporting documents such as published papers or summaries of ongoing studies. Any external funding must be disclosed. A minimum of two recommendations is required. The submitted research must have Institutional Review Board approval.
Deadline for applications is May 15, 2013.
For more information and an application, see Young Scientist Research Fund Awards.
Questions? Contact email@example.com.]]>
Carolyn Pizoli MD/PhD
The honor of receiving the Child Neurology Foundation Scientific Award has had a profound impact on me professionally by providing the essential means to continue my research of network changes in pediatric traumatic brain injury during this critical transition between fellowship training and an independently- funded research career. The impact on me personally is equally great, providing an inspiring vote of confidence that strengthens my resolve to improve the quality of life of the patients we serve through research and advocacy]]>
Infantile Spasms Heroes Award to Dr Ali Mostajelean
Scientific Research Award to Carolyn Pizoli, MD/PhD
Shields Award to Mai revi Mazumdar, MD MPH
Logan Infantile Spasms Award to Alex Paciorkowski, MD, FACMG, FAAP
Swaiman Medical Scholarship Award to:
and Kimberly Worcester
And our CNF Advocacy Awards to:
Children & Adults with Attention Deficit Didorder (CHADD)
and the Sturge-Weber Foundation
Nominations are now being accepted to the 2013 awards]]>
The Philadelphia Eagles today announced they will be collaborating with the Child Neurology Foundation (CNF) to sponsor a program
for first and second-year students from the six regional medical schools in the Delaware Valley. The program promotes the neurological specialty, which cares for the one-in-four children who face problems that affect the developing nervous system.
Students will have the opportunity to hear directly from child neurologists as well as families who can describe their personal experiences. This marks the third time that the Eagles and CNF have partnered together.
Click here to read full article]]>
“One out of four children have a neurologic problem, and it will take everyone’s advocacy to ensure the best quality of life for all affected children,” said Lawrence W. Brown, MD, Associate Professor of Neurology and Pediatrics at the Children’s Hospital of Philadelphia and President of the Child Neurology Foundation. “Questcor has shown outstanding corporate responsibility and leadership demonstrating how industry can be full partners with physicians, scientists and parents to achieve this goal.”
Questcor makes the drug H.P Acthar Gel which was cleared for marketing by the U.S. Food and Drug Administration in 2010 as a treatment for infantile spasms. For the past three years, the company has supplied an unrestricted educational grant to the CNF to fund Infantile Spasms Awareness Week. The goal of IS Awareness Week is to provide pediatricians, child neurologists, parents, and caregivers with objective educational tools which will help increase awareness and understanding of infantile spasms.
As part of this education effort, CNF has developed a website, www.infantilespasmsinfo.org, an educational IS brochure and DVD that provides information on IS from leading child neurologists and shares stories from families coping with this devastating condition. Questcor also provided CNF a grant for the IS Hero Award which recognizes a deserving child neurologist and medical institution, nominated by a parent, for making a positive difference in the life of a child with IS. In addition, the company funds a yearly IS research grant.
Dr. Brown noted that in addition to specific initiatives focused on infantile spasms that Questcor supports the Swaiman Medical Scholarship Program, a mentoring program funded by the CNF that provides up to 10 summer clinical research scholarships. He also praised the company for making a 10-year commitment to funding the Child Neurology Society’s Phillip R. Dodge Young Investigator Award.
John Stone, executive director of the CNF, said Questcor also was being recognized for their comprehensive patient assistance programs put in place by the company to ensure timely access to Acthar for all children with IS regardless of insurance or economic status. Stone said the company also provides one vial of Acthar free of charge to interested children’s hospitals so that care can begin immediately. Nearly 150 hospitals participate.
“Questcor has truly stepped up to the plate when it comes to serving its patient population,” Stone said.
Steve Cartt, Executive Vice President and Chief Business Officer for Questcor, accepted the Corporate Citizenship Award on behalf of the company this past Saturday at CNF’s annual fundraiser in Minneapolis.
“We are very honored to receive this recognition from the Child Neurology Foundation,” Cartt said. “Further research into infantile spasms is imperative and we feel strongly about supporting initiatives that will advance the knowledge and treatment of this devastating condition. We also feel very strongly about supporting the child neurology community in general and to help advance the cause of research and education.”]]>